CAFTA;free trade agreement;imported products quality;regional trade policy uncertainty;the difference in difference method 摘要 We study the impact of regional trade policy uncertainty on the product quality imported from ASEAN ...
OFFICIALS: CAFTA APPROVAL BECOMING UNCERTAIN.(Central American Free Trade Agreement)
CAFTACentral American Free Trade Agreement(aka Central American Free Trade Area) CAFTAChina-ASEAN (Association of Southeast Asian Nations) Free Trade Area CAFTACanadian Agri-Food Trade Alliance CAFTACanadian Advocates for Tax Awareness(Ontario, Canada) ...
中国-柬埔寨自由贸易协定原产地证简称:中柬FTA原产地证,中柬CAFTA原产地证、柬埔寨FTA原产地证等等;英文全称:CHINA-CAMBODIAFREEAGREEMENT CERTIFICATEOFORIGIN.中文全称:中华人民共和国政府和柬埔寨王国政府自由贸易协定原产地证明书。于2022年1月1日正式生效施行双方自由贸易协定安排中方对柬埔寨终实现零关税的产品达到全部...
The impact of free trade agreements on information technology based business The result was a plethora of trade pacts, including CAFTA-DR (Dominican Republic-Central American Free Trade Agreement), plus agreements with Australia, Chile, Singapore, Bahrain and Morocco. Obama administration's options to...
中美洲自由贸易协定(Central American Free Trade Agreement) 在中美洲自由贸易协定(CAFTA)上,最近经美国国会通过的CAFTA是美国与中美洲六个国家签署的自由贸易协定。今年(20… www.tcoc.org.tw|基于261个网页 3. 中国东盟自由贸易区 曹亮教授从中国东盟自由贸易区(CAFTA)的现状出发,基于GTAP模型详细分析了CAFTA的贸...
The Rules of Origin for the U.S.-Central American and Dominican Republic Free Trade Agreement (CAFTA-DR) were largely modeled upon the North American Free Trade Agreement (NAFTA) and the U.S.-Chile Free Trade Agreement. There are, however, some important differences that require the close at...
对CAFTA原产地规则实质性变更标准进行完善将是CAFTA寻求进一步发展的必然要求。 关键词:原产地规则;实质性变更;从价百分比;税目改变原则;加工工序标准 《中国-东盟自由贸易协定》(China-ASEAN Free Trade Agreement,简称CAFTA),是中国加入到区域一体化浪潮中,签订的规模最大的自由贸易协定(Free Trade Agreement,简称FTA)...
解析 中美洲自由贸易协定全称为“美国—多米尼加—中美洲自由贸易协定(U.S.-Dominican Republic-Central America Free Trade Agreement,DR-CAFTA)”,它由美国、多米尼加与中美洲共同市场(Central American Common Ma... 分析总结。 中美洲自由贸易协定全称为美国多米尼加中美洲自由贸易协定us...
the Central American Free Trade Agreement, or CAFTA. The agreement, which may be ratified by the end of the month, will force its signatories to strengthen protections on patents owned by multinational pharmaceutical companies, thus preventing the manufacture and ...